Product

Programmed Cell Death-1 Inhibitor

Aliases

Programmed Cell Death-1 (PD-1) Inhibitor

1 clinical trial

1 indication

Indication

Advanced Solid Tumor Cancer

Clinical trial

A Phase 1, Multi-center, Open Label First-in-Human Study With ABBV-CLS-484 Alone and in Combination in Subjects With Locally Advanced or Metastatic Tumors

Status: Recruiting, Estimated PCD: 2025-08-18